and nutrients into the degenerated disc. Unlike existing symptom-focused treatments, the Discure System has the potential to be the first disease-modifying solution for DDD, designed to reduce the use ...
today announced that the U.S. Food and Drug Administration (“FDA”) has granted Fast Track designation to the BRTX-100 program for the treatment chronic lumbar disc disease (“cLDD”).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results